Transmucosis
Chemicals & Related Products · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6855 Creekside Rd, Clarksville, Maryland...Website
www.transmucosis.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Transmucosis
Transmucosis specializes in developing innovative vaccines that activate both mucosal and systemic immune responses to combat respiratory viruses, including COVID-19 and influenza. Their unique protein-based vaccination platform leverages the FcRn receptor to enhance vaccine efficacy against rapidly evolving pathogens. The company aims to provide broad protection through vaccines that combine multiple variant antigens or target conserved regions. Transmucosis is focused on addressing the challenges posed by current vaccines in keeping pace with emerging viral threats.Explore more
Popular SearchesTransmucosis LLCSIC Code 28,283NAICS Code 32,325Show more
Transmucosis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Transmucosis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Transmucosis has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Transmucosis launches new products
Check out if Transmucosis is spiking on competitors!
Check if Transmucosis has recently received funding, and reach out quickly before it becomes old news!
Transmucosis, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Transmucosis recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Transmucosis
Click to see if Transmucosis had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Transmucosis as Masked Content
Find 3 more new buyers
Compare Similar Companies to Transmucosis
Compare insights from companies similar to Transmucosis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
1989
JC
Joseph CotropiaChief Scientific Officer and Board of Directors of Enzolytics, Inc.
Transmucosis Tech Stack
A closer look at the technologies used by Transmucosis
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Transmucosis
Sign Up For FreeTo access detailed company insights
Transmucosis specializes in developing innovative vaccines that activate both mucosal and systemic immune responses to combat respiratory viruses, including COVID-19 and influenza. Their unique protein-based vaccination platform leverages the FcRn receptor to enhance vaccine efficacy against rapidly evolving pathogens. The company aims to provide b... Read More
